Tekni-Plex purchases Lameplast 

Wayne, Pa, July 2, 2019. Tekni-Plex has purchased Italian healthcare packaging company Lameplast SpA from Milan-based private equity firm Aksìa Group. Lameplast will become part of Tekni-Plex’s global Tekni-Films business.

Headquartered in Rovereto sul Secchia near Modena, the company is a leading Italian manufacturer of plastic single/multi-dose containers for pharmaceutical, diagnostic, medical device, veterinary and cosmetic applications, with an emphasis on ophthalmic, vaccine, vaginal and rectal applications. Lameplast is also known for its injection molding, blow molding and injection blow molding expertise which enables it to produce custom packaging solutions for demanding applications.
«We continue to drive our strategy by growing our business organically and through mergers and acquisitions (M&A). We have specifically focused on expanding our healthcare packaging offerings, with M&A in product or technology adjacencies. Lameplast brings Tekni-Plex specific expertise in unit and multi-dose packaging that was not part of our portfolio previously. We will now be able to offer a rigid packaging solution for prescription and over-the-counter medications and vaccines, in addition to our Tekni-Films flexible packaging options. These products are one more way we can provide value to healthcare and cosmetic companies around the world» said Paul Young, president and chief executive officer, Tekni-Plex.
Lameplast’s quality management system is ISO 15378 and ISO 9001 certified; it is also a CE-mark holder for Class I medical devices, which indicates compliance with applicable European Union (EU) regulations and enables the commercialization of products in the 32 EU countries.
Production is carried out in Class ISO 7 (Class 10,000) and ISO 8 (Class 100,000) controlled contamination environments according to ISO 14644-1. The acquisition adds approximately 130 experienced employees to the more than 3,000-strong global Tekni-Plex team. Lameplast General Manager Luca Iulli will continue to oversee the operation.

Il sistema di gestione della qualità dell’azienda è certificato ISO 15378 e ISO 9001. Lameplast detiene anche il marchio CE per i dispositivi medici di Classe I, che indica la conformità alle normative applicabili dell’Unione Europea (UE) e consente la commercializzazione di prodotti nei 32 paesi dell’UE. La produzione viene eseguita in ambienti di contaminazione controllata di Classe ISO 7 (Classe 10.000) e ISO 8 (Classe 100.000) secondo ISO 14644-1.
Circa 130 dipendenti esperti si aggiungono così al team Tekni-Plex globale (oltre 3.000 dipendenti). Il direttore generale di Lameplast Luca Iulli continuerà a supervisionare le operazioni.